A meta-analysis of prospective randomized controlled trials evaluating endovascular therapies for acute ischemic stroke

Journal of NeuroInterventional Surgery

Volumn 7, Issue 2, 2015, Pages 84-89

  Fargen, Kyle M ^a   Neal, Dan ^a   Fiorella, David J ^b   Turk, Aquilla S ^c   Froehler, Michael ^d   Mocco, J ^e  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d VANDERBILT UNIVERSITY   (United States)

^e Department of Neurosurgery ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD VESSEL OCCLUSION; BRAIN ISCHEMIA; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; DISEASE ASSOCIATION; ENDOVASCULAR SURGERY; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RANKIN SCALE; TREATMENT OUTCOME; TREATMENT PLANNING; STANDARDS; STROKE;

FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

BRAIN ISCHEMIA; ENDOVASCULAR PROCEDURES; FIBRINOLYTIC AGENTS; HUMANS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STROKE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84920982936     PISSN: 17598478     EISSN: 17598486     Source Type: Journal    
DOI: 10.1136/neurintsurg-2014-011543     Document Type: Article

References (14)

1. [No authors listed]. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333: 1581-7.
2. Broderick JP, Palesch YY, Demchuk AM, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013;368: 893-903.
3. Kidwell CS, Jahan R, Gornbein J, et al. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med 2013;368: 914-23.
4. Ciccone A, Valvassori L, Nichelatti M, et al. Endovascular treatment for acute ischemic stroke. N Engl J Med 2013;368: 904-13.
5. Chimowitz MI. Endovascular treatment for acute ischemic stroke-still unproven. N Engl J Med 2013;368: 952-5.
6. Albuquerque FC, Fiorella D, Hirsch JA, et al. The tribulations of stroke trials. J Neurointerv Surg 2013;5: 181-3.
7. Khalessi AA, Fargen KM, Lavine S, et al. Commentary: Societal statement on recent acute stroke intervention trials: Results and implications. Neurosurgery 2013;73: E375-9.
8. Dippel D, Berkhemer O, Fransen P, et al. Results of the multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke in the Netherlands. 9th World Stroke Conference; 25 October 2014, Istanbul, Turkey.
9. Viechtbauer W. Conducting meta-analyses in R with the Metafor package. J Stat Software 2010;36: 1-46.
10. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: A randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282: 2003-11.
11. Ogawa A, Mori E, Minematsu K, et al. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: The middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke 2007;38: 2633-9.
12. Demchuk AM, Goyal M, Yeatts SD, et al. Recanalization and Clinical Outcome of Occlusion Sites at Baseline CT Angiography in the Interventional Management of Stroke III Trial. Radiology 2014;273: 202-10.
13. Nogueira RG, Lutsep HL, Gupta R, et al. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): A randomised trial. Lancet 2012;380: 1231-40.
14. Saver JL, Jahan R, Levy EI, et al. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): A randomised, parallel-group, non-inferiority trial. Lancet 2012;380: 1241-9.